Elixinol Long Term Debt vs Other Current Liab Analysis

EXL Stock

0.05 0.01 31.43%

Elixinol Wellness financial indicator trend analysis is much more than just examining Elixinol Wellness latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Elixinol Wellness is a good investment. Please check the relationship between Elixinol Wellness Long Term Debt and its Other Current Liab accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Long Term Debt vs Other Current Liab

Long Term Debt vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Elixinol Wellness Long Term Debt account and Other Current Liab. At this time, the significance of the direction appears to have totally related.

The correlation between Elixinol Wellness' Long Term Debt and Other Current Liab is 0.99. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Elixinol Wellness Limited, assuming nothing else is changed. The correlation between historical values of Elixinol Wellness' Long Term Debt and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Elixinol Wellness Limited are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Long Term Debt i.e., Elixinol Wellness' Long Term Debt and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Long Term Debt

Long-term debt is a debt that Elixinol Wellness has held for over one year. Long-term debt appears on Elixinol Wellness Limited balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Elixinol Wellness Limited balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Other Current Liab

Most indicators from Elixinol Wellness' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Elixinol Wellness current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, Elixinol Wellness' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to 3,150 in 2024, whereas Discontinued Operations is likely to drop (2.4 M) in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	9.4M	6.7M	3.4M	3.2M
Cost Of Revenue	15.6M	10.3M	5.0M	4.8M

Total Operating Expenses Cost Of Revenue

Elixinol Wellness fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Deferred Long Term Liab	Short Long Term Debt Total	Property Plant And Equipment Net
Total Assets		0.62	0.63	0.81	0.83	0.77	0.85	0.67	0.73	0.7	0.63	0.68	0.62	0.47	0.13	0.13	0.67	0.66	0.68	0.85	0.59	-0.81	0.69	0.49	-0.32	0.16
Other Current Liab	0.62		1.0	0.05	0.88	0.72	0.2	0.93	0.2	0.97	0.99	0.99	1.0	0.49	0.42	0.79	0.99	0.99	0.98	0.74	1.0	-0.38	0.99	0.07	-0.06	-0.02
Total Current Liabilities	0.63	1.0		0.07	0.89	0.73	0.21	0.96	0.23	0.97	0.99	0.99	1.0	0.48	0.41	0.8	1.0	0.98	0.98	0.75	0.99	-0.38	0.99	0.06	-0.08	-0.03
Total Stockholder Equity	0.81	0.05	0.07		0.39	0.46	0.92	0.16	0.79	0.18	0.06	0.12	0.05	0.27	-0.11	-0.43	0.11	0.11	0.13	0.55	0.0	-0.73	0.14	0.57	-0.31	0.27
Other Liab	0.83	0.88	0.89	0.39		0.62	0.6	0.84	0.4	0.85	0.91	0.93	0.9	0.26	0.05	0.52	0.92	0.85	0.95	0.71	0.88	-0.75	0.89	0.26	-0.45	-0.23
Net Tangible Assets	0.77	0.72	0.73	0.46	0.62		0.34	0.79	0.63	0.83	0.68	0.71	0.68	0.85	0.67	0.43	0.72	0.79	0.66	0.98	0.67	-0.27	0.78	0.32	0.29	0.58
Retained Earnings	0.85	0.2	0.21	0.92	0.6	0.34		0.23	0.65	0.28	0.24	0.29	0.23	0.08	-0.32	-0.32	0.28	0.22	0.33	0.47	0.18	-0.93	0.27	0.53	-0.58	-0.06
Accounts Payable	0.67	0.93	0.96	0.16	0.84	0.79	0.23		0.39	0.91	0.93	0.95	0.93	0.5	0.44	0.79	0.94	0.93	0.91	0.83	0.92	-0.34	0.94	0.06	-0.09	0.04
Cash	0.73	0.2	0.23	0.79	0.4	0.63	0.65	0.39		0.26	0.21	0.25	0.19	0.28	0.05	-0.01	0.25	0.24	0.22	0.74	0.14	-0.46	0.26	0.61	-0.15	0.27
Other Assets	0.7	0.97	0.97	0.18	0.85	0.83	0.28	0.91	0.26		0.95	0.96	0.96	0.66	0.52	0.67	0.97	0.98	0.94	0.81	0.96	-0.4	0.99	0.14	0.05	0.18
Long Term Debt	0.63	0.99	0.99	0.06	0.91	0.68	0.24	0.93	0.21	0.95		1.0	1.0	0.4	0.33	0.79	1.0	0.97	0.99	0.71	0.99	-0.43	0.98	0.09	-0.16	-0.12
Net Receivables	0.68	0.99	0.99	0.12	0.93	0.71	0.29	0.95	0.25	0.96	1.0		1.0	0.44	0.34	0.76	1.0	0.97	0.99	0.75	0.99	-0.47	0.99	0.08	-0.17	-0.08
Short Term Investments	0.62	1.0	1.0	0.05	0.9	0.68	0.23	0.93	0.19	0.96	1.0	1.0		0.42	0.36	0.79	1.0	0.98	0.99	0.71	1.0	-0.42	0.99	0.07	-0.13	-0.1
Inventory	0.47	0.49	0.48	0.27	0.26	0.85	0.08	0.5	0.28	0.66	0.4	0.44	0.42		0.83	0.2	0.46	0.59	0.38	0.72	0.44	0.03	0.55	0.09	0.63	0.85
Other Current Assets	0.13	0.42	0.41	-0.11	0.05	0.67	-0.32	0.44	0.05	0.52	0.33	0.34	0.36	0.83		0.43	0.36	0.52	0.25	0.52	0.39	0.4	0.44	0.02	0.76	0.75
Other Stockholder Equity	0.13	0.79	0.8	-0.43	0.52	0.43	-0.32	0.79	-0.01	0.67	0.79	0.76	0.79	0.2	0.43		0.76	0.75	0.71	0.44	0.8	0.14	0.73	-0.1	0.06	-0.18
Total Liab	0.67	0.99	1.0	0.11	0.92	0.72	0.28	0.94	0.25	0.97	1.0	1.0	1.0	0.46	0.36	0.76		0.98	0.99	0.75	0.99	-0.45	0.99	0.11	-0.13	-0.06
Long Term Investments	0.66	0.99	0.98	0.11	0.85	0.79	0.22	0.93	0.24	0.98	0.97	0.97	0.98	0.59	0.52	0.75	0.98		0.95	0.79	0.97	-0.36	0.99	0.09	0.01	0.1
Short Long Term Debt	0.68	0.98	0.98	0.13	0.95	0.66	0.33	0.91	0.22	0.94	0.99	0.99	0.99	0.38	0.25	0.71	0.99	0.95		0.7	0.98	-0.53	0.98	0.11	-0.22	-0.15
Total Current Assets	0.85	0.74	0.75	0.55	0.71	0.98	0.47	0.83	0.74	0.81	0.71	0.75	0.71	0.72	0.52	0.44	0.75	0.79	0.7		0.68	-0.41	0.79	0.4	0.1	0.43
Short Term Debt	0.59	1.0	0.99	0.0	0.88	0.67	0.18	0.92	0.14	0.96	0.99	0.99	1.0	0.44	0.39	0.8	0.99	0.97	0.98	0.68		-0.37	0.98	0.04	-0.09	-0.08
Common Stock	-0.81	-0.38	-0.38	-0.73	-0.75	-0.27	-0.93	-0.34	-0.46	-0.4	-0.43	-0.47	-0.42	0.03	0.4	0.14	-0.45	-0.36	-0.53	-0.41	-0.37		-0.42	-0.35	0.7	0.3
Property Plant Equipment	0.69	0.99	0.99	0.14	0.89	0.78	0.27	0.94	0.26	0.99	0.98	0.99	0.99	0.55	0.44	0.73	0.99	0.99	0.98	0.79	0.98	-0.42		0.12	-0.04	0.05
Deferred Long Term Liab	0.49	0.07	0.06	0.57	0.26	0.32	0.53	0.06	0.61	0.14	0.09	0.08	0.07	0.09	0.02	-0.1	0.11	0.09	0.11	0.4	0.04	-0.35	0.12		-0.12	0.15
Short Long Term Debt Total	-0.32	-0.06	-0.08	-0.31	-0.45	0.29	-0.58	-0.09	-0.15	0.05	-0.16	-0.17	-0.13	0.63	0.76	0.06	-0.13	0.01	-0.22	0.1	-0.09	0.7	-0.04	-0.12		0.8
Property Plant And Equipment Net	0.16	-0.02	-0.03	0.27	-0.23	0.58	-0.06	0.04	0.27	0.18	-0.12	-0.08	-0.1	0.85	0.75	-0.18	-0.06	0.1	-0.15	0.43	-0.08	0.3	0.05	0.15	0.8

Click cells to compare fundamentals

Elixinol Wellness Account Relationship Matchups

Elixinol Wellness fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	121.1M	42.5M	25.3M	13.5M	11.7M	11.1M
Other Current Liab	3.1M	2.1M	2.1M	1.3M	1.6M	1.5M
Total Current Liabilities	6.0M	5.0M	4.7M	3.4M	5.0M	4.7M
Total Stockholder Equity	111.4M	35.7M	19.1M	9.2M	6.5M	6.1M
Net Tangible Assets	71.4M	34.7M	18.6M	9.0M	8.1M	7.7M
Retained Earnings	(86.5M)	(191.1M)	(208.1M)	(218.6M)	(226.2M)	(214.8M)
Accounts Payable	1.8M	1.8M	1.4M	1.1M	1.8M	1.7M
Cash	20.2M	27.7M	12.6M	2.9M	708K	672.6K
Other Assets	724K	4.3M	0.0	183K	1.0	0.95
Net Receivables	1.6M	1.2M	628K	718K	1.7M	1.6M
Inventory	21.3M	4.7M	2.2M	1.7M	3.7M	3.5M
Other Current Assets	8.2M	1.9M	4.1M	4.0M	2.1M	2.0M
Other Stockholder Equity	79K	9.0M	9.1M	9.1M	8.2M	5.4M
Total Liab	9.7M	6.8M	6.3M	4.3M	5.2M	5.0M
Long Term Investments	8.4M	2.3M	2.6M	2.8M	2.5M	2.4M
Total Current Assets	51.4M	35.4M	19.6M	9.3M	8.2M	7.8M
Short Term Debt	989K	802K	1.2M	1.0M	1.1M	1.0M
Common Stock	188.8M	217.7M	218.1M	218.1M	222.6M	184.2M
Property Plant Equipment	17.0M	3.9M	2.5M	1.1M	1.0M	950.8K
Short Long Term Debt Total	4.7M	2.7M	2.6M	1.8M	1.3M	2.1M
Property Plant And Equipment Net	17.0M	3.9M	2.5M	1.1M	1.2M	1.1M
Current Deferred Revenue	157K	89K	94K	22K	522K	548.1K
Net Debt	(15.6M)	(25.1M)	(10.0M)	(1.0M)	554K	581.7K
Non Current Assets Total	69.7M	7.1M	5.7M	4.2M	3.5M	3.4M
Non Currrent Assets Other	(28.2M)	(7.1M)	(5.6M)	(4.1M)	54K	56.7K
Cash And Short Term Investments	20.2M	27.7M	12.6M	2.9M	708K	672.6K
Common Stock Shares Outstanding	197.0M	230.7M	404.8M	406.4M	608.7M	639.1M
Liabilities And Stockholders Equity	121.1M	42.5M	25.3M	13.5M	11.7M	11.1M
Non Current Liabilities Total	3.7M	1.8M	1.5M	887K	261K	248.0K
Net Invested Capital	111.4M	35.9M	19.8M	9.7M	7.2M	6.8M
Property Plant And Equipment Gross	17.0M	3.9M	6.7M	6.4M	5.2M	7.3M
Net Working Capital	45.3M	30.4M	14.9M	5.9M	3.2M	3.0M
Intangible Assets	40.0M	917K	463K	152K	2.3M	2.2M
Long Term Debt Total	3.7M	1.7M	1.5M	818K	940.7K	1.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elixinol Stock Analysis

When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC